Congratulations to ACCP member Sara R. Vazquez and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/qQAy50R5UhO

Pharmacotherapy #MakingAnImpact #TwitteRx #ACCP

Congratulations to ACCP member Christie Schumacher and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/uS0J50R5IVq

Pharmacotherapy Christie Schumacher #MakingAnImpact #TwitteRx #ACCP

Updates on the strategies, regimens and duration of the treatment of pulmonary drug-resistant tuberculosis in our newest podcast. buff.ly/4aFGsst ACCP INFD PRN

Nearly half of the patients included in this study did not receive recommended first-choice therapies; however, racial and ethnic disparities were not identified. buff.ly/3TDyjy3 ACCP INFD PRN

Congratulations to ACCP member Jason Hecht and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/khGP50R5I7k

Pharmacotherapy #MakingAnImpact #TwitteRx #ACCP

C(min) should not be used as a surrogate marker for a therapeutic AUC(0–24) in pediatric patients buff.ly/4asr2Z7 ACCP INFD PRN

This study aimed to develop a population kinetic-pharmacodynamic (K-PD) model for oxytocin-induced uterine contractions considering real-world data and relevant influencing factors to establish an optimal starting dosing regimen for intravenous oxytocin. buff.ly/3P7nzq4

Pharmacotherapy Publications, Inc. is calling for proposals for both ACCP journals! Interested? Click here: ow.ly/GXqf50QWKuT
JACCP Pharmacotherapy

Disparities in UTI Treatment Among Male Veterans 🩺💊👨‍⚕️

📊 Only 50.6% received recommended first-choice therapy.
👥 Age 18-49 predicted adherence to recommended therapy.
🚫 No identified racial or ethnic disparities.

#UTI #VeteransHealth #AntibioticStewardship

Nearly half of the patients included in this study did not receive recommended first-choice therapies; however, racial and ethnic disparities were not identified. buff.ly/3TDyjy3 ACCP INFD PRN

The March issue is live at: buff.ly/48XzlKA

💉🤰 Struggling to find the right dose for oxytocin during labor induction? 🤔 This study developed a model to optimize dosing regimens, considering factors like parity and cervical dilation. Find out how personalized dosing could improve outcomes
#LaborInduction #MaternalHealth

This study aimed to develop a population kinetic-pharmacodynamic (K-PD) model for oxytocin-induced uterine contractions considering real-world data and relevant influencing factors to establish an optimal starting dosing regimen for intravenous oxytocin. buff.ly/3P7nzq4

In this case series, we describe the outcomes of six patients who were transitioned from UFH to bivalirudin during their course of VV ECMO support as a bridge to lung transplantation. buff.ly/4bDIudZ @accpimtrprn

Pharmacotherapy Publications, Inc. is calling for proposals for both ACCP journals! Pharmacotherapy seeks drug-/drug class-specific consensus recommendations and JACCP seeks clinical pharmacy practice consensus recommendations. Learn more: ow.ly/gAHM50QF6O5

👶🦠 Optimizing antibiotic therapy for pediatric pneumonia: Insights from pharmacokinetics and susceptibility data. 💊 High-dose amoxicillin emerges as a potential regimen, ensuring adequate exposure against resistant strains. 📊

#Pediatrics #AntibioticResistance 🏥

New evidence supports the use of shorter duration, all-oral regimens, which represent an encouraging treatment strategy for drug-resistant TB. buff.ly/3w1iRn6 ACCP INFD PRN @accppulmprn

The decision to prescribe specific pain management therapies in patients with CVD should include assessment of pain severity, type of pain, drug–drug/disease interactions, adjuvant therapies required, and the risk or presence of AEs. buff.ly/48kk9HW ACCP PPC PRN

Explore how to mitigate, monitor for, and establish clinically relevant thresholds of clozapine-associated inflammation. buff.ly/48bhe3n ACCP CNS PRN

With limited viable salvage treatment options, combination eravacycline therapy showed favorable microbiological and clinical outcomes in patients with CRAB pneumonia. buff.ly/49BNqyn ACCP INFD PRN